Templeman Blaine
Chief Legal Officer at CHINOOK THERAPEUTICS, INC.
- Sold, on record
- $348k
- Dollars the filings state
- Form 4 sales
- 15
- Latest Sep 15, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CHINOOK THERAPEUTICS, INC.Chief Legal Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedSep 13 2018
Sold 6,056 shares at $6.50 ($39k)
Templeman Blaine, Executive VP, General Counsel
Sold 4.1% of holdings ($958k position)141,381 shares left2.1x usual sizeFiling
- 2 Form 4 sale CHINOOK THERAPEUTICS, INC.UnusualSep 24 +11 days
Sold 10,262 shares at $5.81 ($60k)
Templeman Blaine, Chief Legal Officer
Sold 7.3% of holdings ($821k position)131,119 shares left3.6x usual sizeFiling
- 3 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedNov 20 +57 days
Sold 843 shares at $2.91 ($2k)
Templeman Blaine, Chief Legal Officer
Sold 0.6% of holdings ($384k position)131,119 shares left0.3x usual sizeFiling
- 4 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedDec 12 +22 days
Sold 1,241 shares at $2.93 ($4k)
Templeman Blaine, Chief Legal Officer
Sold 0.9% of holdings ($384k position)129,878 shares left0.4x usual sizeFiling
- 5 Form 4 sale CHINOOK THERAPEUTICS, INC.UnusualSep 13 +275 days
Sold 12,878 shares at $1.31 ($17k)
Templeman Blaine, Chief Legal Officer
Sold 9.9% of holdings ($170k position)117,000 shares left4.5x usual sizeFiling
- 6 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedDec 12 +90 days
Sold 1,264 shares at $1.16 ($1k)
Templeman Blaine, Chief Legal Officer
Sold 1.1% of holdings ($138k position)117,736 shares left0.4x usual sizeFiling
- 7 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedAug 7 +239 days
Sold 7,951 shares at $2.55 ($20k)
Templeman Blaine, Chief Legal Officer
Sold 5.6% of holdings ($363k position)134,285 shares left2.2x usual sizeFiling
- 8 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedSep 15 +39 days
Sold 12,369 shares at $2.39 ($30k)
Templeman Blaine, Chief Legal Officer
Sold 9.2% of holdings ($321k position)121,916 shares left2.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2020 | CHINOOK THERAPEUTICS, INC. | Chief Legal Officer | Form 4 sale | 12,369 | $30k | 9.2% | Plan not stated | SEC |
| Aug 7, 2020 | CHINOOK THERAPEUTICS, INC. | Chief Legal Officer | Form 4 sale | 7,951 | $20k | 5.6% | Plan not stated | SEC |
| Dec 12, 2019 | CHINOOK THERAPEUTICS, INC. | Chief Legal Officer | Form 4 sale | 1,264 | $1k | 1.1% | Plan not stated | SEC |
| Sep 13, 2019 | CHINOOK THERAPEUTICS, INC. | Chief Legal Officer | Form 4 sale | 12,878 | $17k | 9.9% | Unusual | SEC |
| Dec 12, 2018 | CHINOOK THERAPEUTICS, INC. | Chief Legal Officer | Form 4 sale | 1,241 | $4k | 0.9% | Plan not stated | SEC |
| Nov 20, 2018 | CHINOOK THERAPEUTICS, INC. | Chief Legal Officer | Form 4 sale | 843 | $2k | 0.6% | Plan not stated | SEC |
| Sep 24, 2018 | CHINOOK THERAPEUTICS, INC. | Chief Legal Officer | Form 4 sale | 10,262 | $60k | 7.3% | Unusual | SEC |
| Sep 13, 2018 | CHINOOK THERAPEUTICS, INC. | Executive VP, General Counsel | Form 4 sale | 6,056 | $39k | 4.1% | Plan not stated | SEC |
| May 17, 2018 | CHINOOK THERAPEUTICS, INC. | Chief Legal Officer | Form 4 sale | 2,000 | $16k | 2.8% | Plan not stated | SEC |
| Dec 18, 2017 | CHINOOK THERAPEUTICS, INC. | Executive VP, General Counsel | Form 4 sale | 2,884 | $24k | 4.0% | Plan not stated | SEC |
| Nov 17, 2017 | CHINOOK THERAPEUTICS, INC. | Executive VP, General Counsel | Form 4 sale | 243 | $2k | 0.4% | Plan not stated | SEC |
| Sep 18, 2017 | CHINOOK THERAPEUTICS, INC. | Executive VP, General Counsel | Form 4 sale | 2,884 | $32k | 4.7% | Plan not stated | SEC |
| Sep 13, 2017 | CHINOOK THERAPEUTICS, INC. | Executive VP, General Counsel | Form 4 sale | 3,557 | $39k | 5.4% | Plan not stated | SEC |
| May 17, 2017 | CHINOOK THERAPEUTICS, INC. | Executive VP, General Counsel | Form 4 sale | 1,648 | $16k | 4.2% | Plan not stated | SEC |
| Jan 11, 2017 | CHINOOK THERAPEUTICS, INC. | Executive VP, General Counsel | Form 4 sale | 3,785 | $45k | 9.2% | Plan not stated | SEC |